Table 2.
Groups | Non-Carriers | BRCA Carriers | Total | ||||
---|---|---|---|---|---|---|---|
Variables | Cases | 49 | 9 |
58
100% |
|||
85.5% | 15.5% | ||||||
Age | ≤40 years | 7 | 2 |
χ2 Test “p” value 0.6495 |
|||
>40 years | 39 | 7 | |||||
NOS | 3 | 0 | |||||
Mean | 51.6 | 50.3 | |||||
Two-sample t-test ”p” value = 0.788 | |||||||
Family history for
breast cancer |
Yes | 19 | 5 | 0.3475 | |||
No | 30 | 4 | |||||
Diagnostic procedure | CL | 18 | 1 | 0.1086 | |||
CL + BIO | 8 | 4 | |||||
OP + HP | 23 | 4 | |||||
Histogenetic type | NOS | 16 | 1 | 0.187 | |||
F-C Ch | 5 | 0 | |||||
M | 28 | 8 | |||||
Histopathological
diagnosis |
NCO | 18 | 1 | 0.494 | |||
NN | 3 | 0 | |||||
Malignancies | DCIS | 28 | 1 | 8 | 0 | ||
IDC | 19 | 7 | |||||
ILC | 5 | 1 | |||||
Mixed | 2 | 0 | |||||
MUC | 1 | 0 | |||||
Molecular
classification |
NCO | 23 | 2 | 0.0034 | |||
L-A | 12 | 1 | |||||
L-B | 7 | 1 | |||||
HER2+ | 5 | 0 | |||||
T-N | 2 | 5 |
Legend: BIO = Biopsy; CL = Clinical diagnosis; DCIS = Ductal Carcinoma In Situ; IDC = Invasive Ductal Carcinoma; F-C Chs = Fibro-cystic changes; HP = Histopathology; ILC = Invasive Lobular Carcinoma; L-A = Luminal A type; L-B = Luminal B type; NCO = Not Carried Out; T-N = Triple-Negative; NCO = Not Carried Out; NN = Non-Neoplastic lesions; NOS = Not Otherwise Specified; M = Malignancies; Mixed = IDC+ ILC; MUC = Mucinous; OP = Surgical procedure.